News
New mechanism for cancer progression discovered by UNC and Harvard researchers
The protein Ras plays an important role in cellular growth control. Researchers have focused on the protein because mutations in its gene are found in more than 30 percent of all cancers, making it the most prevalent human oncogene.
Research reveals new understanding of X chromosome inactivation
Chapel Hill, NC – In a paper published in the Nov. 21 issue of Cell, a team led by Mauro Calabrese, a postdoctoral fellow at the University of North Carolina in the lab of Terry Magnuson, chair of the department of genetics and member of the UNC Lineberger Comprehensive Cancer Center, broadens the understanding of how cells regulate silencing of the X chromosome in a process known as X-inactivation.
Hayes interview by NC Now on lung cancer research
Neil Hayes, MD, MPH, talks to North Carolina Now about new research into lung cancer. The interview aired on the show's Nov. 12, 2012 broadcast.
Ethan Basch joins UNC Lineberger to lead cancer outcomes research program
Chapel Hill, NC – Ethan Basch, MD, has joined the Lineberger Comprehensive Cancer Center at the University of North Carolina School of Medicine. Basch will be an associate professor of medicine and director of the cancer outcomes research program.
Two UNC Lineberger supporters honored with Davie Award
Two UNC Board of Trustees members and longtime UNC Lineberger supporters were among the seven honored with the William Richardson Davie Award. The Davie Awards are the highest honor bestowed by the UNC Board of Trustees.
Support Week honors and serves patients and caregivers
The 2012 Comprehensive Cancer Support Program Support Week was a huge success. Hundreds of patients and caregivers learned about and participated in activities highlighting the many support services of the Comprehensive Support Program during CCSP Support Week 2012.
2012 Oncology Excellence Award recipients announced
UNC Lineberger Comprehensive Cancer Center and UNC Cancer Care honored four employees with 2012 Excellence Awards.
Olshan named to UNC Lineberger leadership post
Andrew F. Olshan, PhD, has been appointed Associate Director of Population Sciences at UNC Lineberger Comprehensive Cancer Center. This senior leadership position is responsible for overseeing the development of population-based cancer research and its integration throughout the Cancer Center programs. The position also oversees several Cancer Center core resources as well as two established scientific programs, Cancer Epidemiology and Cancer Prevention and Control. Dr. Olshan will continue to serve as head of the Cancer Epidemiology Program and directs two cores, the Biospecimens Processing Facility and Rapid Case Ascertainment Core.
News 14 - North Carolina Children's Hospital's top-notch care fit for a queen
Valerie King is living the teenage dream, she's in the running for homecoming queen. While it's tough competition for the crown, it's nothing compared to the battle she's been fighting for the past year.
Golden and Earp awarded for SOPHE paper of the year
Shelley Golden, MPH, and Jo Anne Earp, ScD, co-wrote an article that received the Lawrence W. Green Paper of the Year Award at the 63rd annual meeting of the Society for Public Health Education (SOPHE), held Oct. 25-27 in San Francisco.
Lilly Oncology on Canvas Art Exhibit on display in the N.C. Cancer Hospital Lobby November 7-21, 2012
UNC Lineberger Comprehensive Cancer Center is hosting the Lilly Oncology on Canvas Exhibition in the lobby of the N.C. Cancer Hospital.
Green joins UNC Lineberger External Affairs
Elizabeth D. Green has joined UNC Lineberger Comprehensive Cancer Center’s Office of External Affairs in the role of major gifts officer. She will work with UNC Lineberger supporters, faculty and staff to enhance awareness of and private support for cancer prevention, research and treatment programs at UNC Lineberger and the N.C. Cancer Hospital.
Patterson elected President of the Association of Professors of Cardiology
The chief of cardiology in the University of North Carolina School of Medicine and member of UNC Lineberger has been elected president of the Association of Professors of Cardiology.
Source Code: Discovering the links between epigenetic tags
UNC researchers discover the first link between epigenetic tags—the chemicals that orchestrate how our genes are expressed and our health maintained or derailed.
New resource for single fathers due to cancer
A new website for Single Fathers Due to Cancer has been launched as a way to help fathers more easily find resources and support.
Komen's 31 Days of Impact features Carey
Dr. Lisa Carey was featured by the Susan G. Komen Foundation as part of its 31 Days of Impact series that profiled men and women who are inspirational in the fight against breast cancer.
McLeod quoted on chemotherapy dosages in Genetic Engineering and Biotechnology News
Genetic Engineering and Biotechnology News interviwed Howard McLeod, PharmD, about the role of physicians and insurance companies in gauging chemotherapy dosages in an article titled "Chemotherapy for the 21st Century" published Oct. 31, 2012.
Van Le Named Palumbo Professor
Linda Van Le, MD, professor of gynecologic oncology and member of the UNC Lineberger Comprehensive Cancer Center, has been appointed the Leonard Palumbo Distinguished Professor of Gynecologic Oncology. This professorship was established in 1986 in honor of Dr. Leonard Palumbo. Because of Dr. Palumbo's long standing commitment to gynecologic oncology it was the family's wish that this professorship be designated as a professorship in gynecologic oncology. Dr. Wesley Fowler, Jr. held the professorship during his nearly forty years of dedicated service to the UNC Department of Obstetrics and Gynecology.
Weissler named vice-chair of the Board of Regents of the American College of Surgeons
Mark C. Weissler, MD, FACS, was elected vice-chair of the Board of Regents of the American College of Surgeons (ACS) during the organization’s 2012 Clinical Congress in Chicago on Sept 30.
UNC physician elected to board of directors for American Society for Radiation Oncology
Lawrence B. Marks, MD, has been elected to a two-year term on the Board of Directors of the American Society for Radiation Oncology (ASTRO).
